Scott Jennings, Hang Pong Ng, Guoshun Wang  Journal of Cystic Fibrosis 

Slides:



Advertisements
Similar presentations
Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1
Advertisements

Comparative ex vivo, in vitro and in silico analyses of a CFTR splicing mutation: Importance of functional studies to establish disease liability of mutations 
Mutations in linker for activation of T cells (LAT) lead to a novel form of severe combined immunodeficiency  Chiara Bacchelli, PhD, Federico A. Moretti,
Azithromycin fails to reduce increased expression of neutrophil-related cytokines in primary-cultured epithelial cells from cystic fibrosis mice  Ximena.
Comparative ex vivo, in vitro and in silico analyses of a CFTR splicing mutation: Importance of functional studies to establish disease liability of mutations 
Volume 5, Issue 1, Pages (July 2015)
Monocyte chemoattractant chemokines in cystic fibrosis
Elevated hepatic SULT1E1 activity in mouse models of cystic fibrosis alters the regulation of estrogen responsive proteins  Li Li, Charles N. Falany 
Ivacaftor potentiation of multiple CFTR channels with gating mutations
A wide methodological approach to identify a large duplication in CFTR gene in a CF patient uncharacterised by sequencing analysis  Lucy Costantino, Damiana.
Evaluation of a systems biology approach to identify pharmacological correctors of the mutant CFTR chloride channel  Emanuela Pesce, Giulia Gorrieri,
Stimulation of β2-adrenergic receptor increases CFTR function and decreases ATP levels in murine hematopoietic stem/progenitor cells  Teresa Trotta, Lorenzo.
Mutations in linker for activation of T cells (LAT) lead to a novel form of severe combined immunodeficiency  Chiara Bacchelli, PhD, Federico A. Moretti,
Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function  Fredrick Van Goor, Haihui Yu, Bill.
Splicing defects in the CFTR gene: Minigene analysis of two mutations, G>C and A>G  Gwendal Dujardin, Diane Commandeur, Catherine Le Jossic-Corcos,
Volume 12, Issue 10, Pages (September 2015)
RASGRP1 mutation in autoimmune lymphoproliferative syndrome-like disease  Huawei Mao, MD, PhD, Wanling Yang, PhD, Sylvain Latour, PhD, Jing Yang, PhD,
Levels of Polyadenylation Factor CstF-64 Control IgM Heavy Chain mRNA Accumulation and Other Events Associated with B Cell Differentiation  Yoshio Takagaki,
Role of IL-9 in the pathophysiology of allergic diseases
by Parisa Asvadi, Zohra Ahmadi, and Beng H. Chong
Effect of VX-770 (Ivacaftor) and OAG on Ca2+ influx and CFTR activity in G551D and F508del-CFTR expressing cells  Laura Vachel, Caroline Norez, Frédéric.
Β1 Integrins with Individually Disrupted Cytoplasmic NPxY Motifs Are Embryonic Lethal but Partially Active in the Epidermis  Alexander Meves, Christopher.
CFTR: Effect of ICL2 and ICL4 amino acids in close spatial proximity on the current properties of the channel  Arnaud Billet, Jean-Paul Mornon, Mathilde.
Correction of a Genetic Disease in Mouse via Use of CRISPR-Cas9
Psoriasis Upregulated Phorbolin-1 Shares Structural but not Functional Similarity to the mRNA-Editing Protein Apobec-1  Peder Madsen, Julio E. Celis,
Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy
Mouse Genome Engineering via CRISPR-Cas9 for Study of Immune Function
Efrat Avigad Laron, Emil Aamar, David Enshell-Seijffers 
Volume 154, Issue 6, Pages (September 2013)
Volume 22, Issue 1, Pages (January 2018)
Volume 65, Issue 1, Pages (January 2017)
Molecular Therapy - Nucleic Acids
Volume 7, Issue 3, Pages (September 2016)
Lucas R. Hoffman, Hemantha D. Kulasekara, Julia Emerson, Laura S
Volume 13, Issue 6, Pages (December 2013)
Function, pharmacological correction and maturation of new Indian CFTR gene mutations  Himanshu Sharma, Mathilde Jollivet Souchet, Isabelle Callebaut,
CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
Therapeutic editing of hepatocyte genome in vivo
USH2A Gene Editing Using the CRISPR System
Molecular Therapy - Nucleic Acids
P. aeruginosa drives CXCL8 synthesis via redundant toll-like receptors and NADPH oxidase in CFTR∆F508 airway epithelial cells  Lucie Roussel, Guy Martel,
Andrew R. Bassett, Charlotte Tibbit, Chris P. Ponting, Ji-Long Liu 
Volume 154, Issue 6, Pages (September 2013)
Simultaneous Reprogramming and Gene Correction of Patient Fibroblasts
Volume 153, Issue 4, Pages (May 2013)
GFP to BFP Conversion: A Versatile Assay for the Quantification of CRISPR/Cas9- mediated Genome Editing  Astrid Glaser, Bradley McColl, Jim Vadolas  Molecular.
Volume 8, Issue 5, Pages (May 2017)
Volume 22, Issue 1, Pages (January 2015)
William T. Hendriks, Curtis R. Warren, Chad A. Cowan  Cell Stem Cell 
Volume 153, Issue 4, Pages (May 2013)
Volume 15, Issue 3, Pages (April 2016)
Volume 25, Issue 2, Pages (February 2017)
Molecular Therapy - Nucleic Acids
Modification of the salivary secretion assay in F508del mice — The murine equivalent of the human sweat test  Karoline Droebner, Peter Sandner  Journal.
Tagging of the endogenous Py03652 gene with the gfp gene in Plasmodium yoelii. Tagging of the endogenous Py03652 gene with the gfp gene in Plasmodium yoelii.
CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients  Claudia Provenzano,
Molecular Therapy - Nucleic Acids
Volume 17, Issue 5, Pages (October 2016)
Ciaran M Lee, Thomas J Cradick, Gang Bao  Molecular Therapy 
Volume 15, Issue 2, Pages (August 2014)
A Lack of Birbeck Granules in Langerhans Cells Is Associated with a Naturally Occurring Point Mutation in the Human Langerin Gene  Pauline Verdijk, Remco.
Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence replacement. Gene editing by CRISPR/Cas9 for gene inactivation and targeted sequence.
Volume 16, Issue 2, Pages (February 2015)
The regulatory domain of HSF1 is involved in the pro-apoptotic response to TNF. (A) Upper panel, functional domains and potential DAPK phosphorylation.
Volume 26, Issue 11, Pages (November 2018)
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Uta Griesenbach, A. Christopher Boyd  Journal of Cystic Fibrosis 
CRISPR Immunological Memory Requires a Host Factor for Specificity
Genome-Edited Triple-Recessive Mutation Alters Seed Dormancy in Wheat
Presentation transcript:

Establishment of a ΔF508-CF promyelocytic cell line for cystic fibrosis research and drug screening  Scott Jennings, Hang Pong Ng, Guoshun Wang  Journal of Cystic Fibrosis  Volume 18, Issue 1, Pages 44-53 (January 2019) DOI: 10.1016/j.jcf.2018.06.007 Copyright © 2018 European Cystic Fibrosis Society Terms and Conditions

Fig. 1 Schematic representation of the human CFTR Exon 11 region and ssOND homology-directed repair (HDR) template. A) The letters NIIFGVS indicate amino acid codons, with the highlighted F being lost in the case of ΔF508 mutation. The CRISPR/Cas9 sgRNA sequence is highlighted in blue, with the corresponding protospacer-adjacent motif (PAM) site highlighted in green. Red arrows indicate the site of the Cas9-induced double strand break (DSB). The HDR template is an ssODN with 36 bp of homology on the PAM-distal side of the DSB and 91 bp of homology on the PAM-proximal side of the DSB. B) The structure of the CFTR gene-editing vector, hCFTR-Cas9-eGFP. T2A: an adapted self-cleaving 2A peptide from picornaviruse to produce equimolar levels of multiple genes from the same mRNA. C) The regional sequence of WT-hCFTR-Exon-11 and the detail sequence of the designed ssODN. Journal of Cystic Fibrosis 2019 18, 44-53DOI: (10.1016/j.jcf.2018.06.007) Copyright © 2018 European Cystic Fibrosis Society Terms and Conditions

Fig. 2 Genotyping of single-cell clones. A) A representative gel image of PCR amplification of CFTR Exon 11 and SspI digestion for multiple single-cell clones. WT (+/+); homozygous ΔF508-CFTR (Δ/Δ); heterozygous ΔF508-CFTR (+/Δ). U: undigested PCR product; C: SspI-digested PCR product. B) Sequence comparison of CFTR Exon-11 region of the NCBI-published WT sequence, designed mutant sequence (ΔF508 + SspI), and an obtained homozygous clone (Δ/Δ) sequence. Journal of Cystic Fibrosis 2019 18, 44-53DOI: (10.1016/j.jcf.2018.06.007) Copyright © 2018 European Cystic Fibrosis Society Terms and Conditions

Fig. 3 Morphological and immunological determination of WT and ΔF508-CF neutrophils derived from the control and CFTR-gene-edited HL-60 cells. A-D) Morphological determination of WT and ΔF508-CF HL-60 cell differentiation. Giemsa staining of non-differentiated (A & C) or differentiated (B & D) HL-60 cells. WT (A & B) and ΔF508-CF (C & D). E-J) Immunological determination of WT and ΔF508-CF HL-60 cell differentiation and their CFTR expression. E & F) CD11b immunostaining. Differentiated (Diff.) or non-differentiated (Undiff.) WT or ΔF508-CF HL-60 cells were stained with an antibody against CD11b or an isotype control antibody (Isotype-Ctrl Ab). G & H) Surface CFTR immunostaining. Differentiated neutrophils from WT or ΔF508-CF HL-60 cells were stimulated with or without PMA, followed by staining with an antibody against an CFTR extracellular domain (CF3 Ab) or an isotype control antibody (Isotype-Ctrl Ab). I) Intracellular CFTR staining. Differentiated WT or ΔF508-CFTR (ΔF508) neutrophils were stained with an anti-CFTR antibody (Ab#450) or an isotype control antibody. J) Intracellular CFTR staining. Differentiated WT or ΔF508-CFTR (ΔF508) neutrophils were stained with an anti-CFTR antibody (Ab#596) or an isotype control antibody. Journal of Cystic Fibrosis 2019 18, 44-53DOI: (10.1016/j.jcf.2018.06.007) Copyright © 2018 European Cystic Fibrosis Society Terms and Conditions

Fig. 4 Oxidant production and microbial killing. A) Phagosomal HOCl production. Differentiated neutrophils from WT or ΔF508-CF HL-60 cells were allowed to phagocytose serum-opsonized P. aeruginosa. Chloride-dependent phagosomal HOCl production was assessed by R19-S oxidation assay. Fluorescence positivity and intensity were measured by flow cytometry, and the total fluorescence of all positive cells for each condition was plotted as percentage increase as related to the 0-mM chloride condition. B) Primitive oxidant production. Differentiated neutrophils from WT or ΔF508-CF HL-60 cells were pre-loaded with dihydrorhodamine 123 (DHR 123) and stimulated with 20 ng/ml PMA for 1 h. Total fluorescence were obtained by flow cytometry. C) Microbial killing. Differentiated neutrophils from WT or ΔF508-CF HL-60 cells were allowed to phagocytose serum-opsonized bacteria at a ratio of 1:5 (cell: bacteria). Chloride-dependent bacterial killing over 40 min at 37 °C was assessed by cell lysis, bacterial plating and colony numeration. Bacterial colony number under 122-mM chloride condition was related to that of 0-mM chloride condition. Journal of Cystic Fibrosis 2019 18, 44-53DOI: (10.1016/j.jcf.2018.06.007) Copyright © 2018 European Cystic Fibrosis Society Terms and Conditions

Fig. 5 Induced apoptosis and chemotaxis. A) Apoptosis. WT and ΔF508-CF neutrophils derived from their corresponding HL-60 cells were stimulated with PMA (20 ng/ml) for 1 h, followed by Annexin-V and propidium iodide stainings. Double asterisks (**) denote a significant difference between two compared groups by Student's t-test (p < .01, n = 4). B) Chemotaxis. WT and ΔF508-CF neutrophils derived from their corresponding HL-60 cells were set to migrate toward a control or an fMLF (100 nM) medium for 1 h. Double asterisks (**) denote a significant difference between two compared groups by Student's t-test (p < .01, n = 5). Journal of Cystic Fibrosis 2019 18, 44-53DOI: (10.1016/j.jcf.2018.06.007) Copyright © 2018 European Cystic Fibrosis Society Terms and Conditions